Innate Pharma (IPHA) Return on Capital Employed [ROCE] (2021 - 2026)
Innate Pharma (IPHA) recorded Return on Capital Employed [ROCE] of -913.03% in the quarter ended Jun 30, 2026, down 754.88 percentage points from -158.15% a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Innate Pharma reported Return on Capital Employed [ROCE] of -112.74%, down 67.73 percentage points from the prior year.
- Annual Return on Capital Employed [ROCE] has a five-year change of -113.12 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -45.01% in the year ended Dec 31, 2024 (-36.77 pp), -8.24% in the year ended Dec 31, 2023 (+19.40 pp), -27.64% in the year ended Dec 31, 2022 (-4.57 pp) and -23.07% in the year ended Dec 31, 2021 (-23.45 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Return on Capital Employed [ROCE] in data going back to the quarter ended Jun 30, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Innate Pharma | 146.20 Mn | 146.20 Mn | - | -913.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -913.03% |
| Dec 31, 2025 | -377.03% |
| Jun 30, 2025 | -158.15% |
| Dec 31, 2024 | -98.41% |
| Jun 30, 2024 | -81.76% |
| Dec 31, 2023 | -81.16% |
| Jun 30, 2023 | -88.95% |
| Dec 31, 2022 | -89.96% |
| Dec 31, 2021 | -46.68% |
| Jun 30, 2021 | -26.47% |
API Access
Innate Pharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();